Table 4 Multivariate analyses of various clinical parameters in prostate cancer patients
Parameters | Progression-Free Survival | Cancer-Specific Survival | Overall Survival | |||
|---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age (years) | 0.975 (0.953–0.997) | 0.028 |  | – |  | – |
Gleason Score |  | < 0.001 |  | < 0.001 |  | < 0.001 |
  ≤ 7 | 1 |  | 1 |  | 1 |  |
  > 7 | 2.392 (1.638–3.495 |  | 5.073 (2.569–10.020) |  | 4.003 (2.298–6.974) |  |
Metastasis |  | < 0.001 |  | < 0.001 |  | < 0.001 |
 No | 1 |  | 1 |  | 1 |  |
 Yes | 2.930 (2.021–4.247) |  | 6.091 (3.086–12.024) |  | 3.245 (1.957–5.378) |  |
PNI | Â | 0.001 | Â | 0.002 | Â | 0.001 |
  < 50.2 | 1 |  | 1 |  | 1 |  |
  ≥ 50.2 | 0.521 (0.355–0.765) |  | 0.421 (0.243–0.728) |  | 0.429 (0.263–0.698) |  |